NASDAQ:ARQT

Arcutis Biotherapeutics Stock Predictions

etoro logo Buy ARQT
*Your capital is at risk
$21.35
+0.560 (+2.69%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ARQT Prediction Chart

ARQT Predictions History

Latest community submissions for ARQT.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 7, 2025 $15.23 +3.40% $14.30 X 93.49% 0
Apr 7, 2025 $15.04 +2.13% $14.30 X 94.80% 0
Apr 7, 2025 Bullish $14.30 X 0
Mar 25, 2025 $16.84 -2.59% $17.11 V 98.43% 1
Mar 25, 2025 $17.01 -1.62% $17.11 V 99.42% 4
Mar 25, 2025 Bullish $17.11 X 0
Apr 30, 2024 $8.47 -3.48% $8.32 V 98.14% 1
Apr 30, 2024 $8.97 +2.17% $8.32 X 92.18% 0
Apr 30, 2024 $9.80 +11.62% $8.32 X 82.21% 0
AlexVel AlexVel Pro
Feb 20, 2024 $9.12 -1.94% $9.48 X 96.20% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ARQT with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ARCUTIS BIOTHERAPEUTICS INC
Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE